438
Participants
Start Date
December 14, 2018
Primary Completion Date
April 26, 2022
Study Completion Date
November 11, 2024
Atezolizumab
Atezolizumab will be administered as per the schedule specified in arm or cohort.
rHuPH20
rHuPH20 will be administered as per the scheduled specified in the cohort for Part 1.
Oncosalud Sac, Lima
Auckland City Hospital, Cancer and Blood Research, Auckland
Református Pulmonológiai Centrum, Törökbálint
Sandton Oncology Medical Group, Sandton
Tauranga Hospital, Clinical Trials Unit, Tauranga
Waikato Hospital - Cancer and Blood Research Trials Unit, Hamilton
Matrai Gyogyintezet, Mátraháza
Consultorio Dr. Miguel Angel Escudero, Salta
Groote Schuur Hospital ( Uni of Capetown ), Cape Town
Clinica CIMCA, San José
ICIMED Instituto de Investigación en Ciencias Médicas, San José
Vajira Hospital, Bangkok
Chulalongkorn Hospital, Bangkok
Rajavithi Hospital, Bangkok
Faculty of Med. Siriraj Hosp., Bangkok
APHM, Marseille
Clínica San Gabriel, Lima
IRCCS Istituto Clinico Humanitas, Rozzano
Prapokklao Hospital, Chanthaburi
Asst Papa Giovanni XXIII, Bergamo
Hospital Universitario La Paz, Madrid
Kartal Dr Lutfi Kirdar Sehir Hastanesi, Istanbul
Medipol University Medical Faculty, Istanbul
Ege Uni Medical Faculty Hospital, Izmir
RCI Sumy Regional Clinical Oncological Dispensary, Sumy
Udonthani Cancer Hospital, Udonthani, Muang,Udonthani
Ico Rene Gauducheau, Saint-Herblain
Municipal Institution City Clinical Hospital #4 of Dnipro City Council, Dnipropetrovsk
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Cuidados oncologicos, Querétaro City
Prince of Songkla University, Hat Yai
FSBI Russian Oncology Research Center n.a. Blokhin of MOH RF, Moscow
Jilin Cancer Hospital, Changchun
MEDSI Clinical Hospital on Pyatnitsky Highway, Moscow
Murmansk Regional Clinical Hospital named after P.A. Bayandin, Murmansk
Jinan Central Hospital, Jinan
Sir Run Run Shaw Hospital Zhejiang University, Hangzhou
Mordovia State University, Saransk
Multidisciplinary clinic Reaviz, Samara
Henan Cancer Hospital, Zhengzhou
Chelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk
Filial #1 Regional Oncology Dispensary of Nizhniy Novgorod, Nizhny Novgorod
West China Hospital - Sichuan University, Chengdu
Oncocentro Apys, Viña del Mar
James Lind Centro de Investigación Del Cáncer, Temuco
Bradford Hill Centro de Investigaciones Clinicas, Recoleta
Fundación CENIT para la Investigación en Neurociencias, Buenos Aires
Centro Oncologico Riojano Integral (CORI), La Rioja
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, Ijuí
INCA 1- Instituto Nacional de Câncer X, Rio de Janeiro
"General Hospital G.Papanikolaou", Asvestochóri
Sotiria Hospital, Athens
INTEGRA Cancer Institute, Guatemala City
Oncomedica, Guatemala City
Grupo Angeles, Guatemala City
Hospital El Pilar, Guatemala City
Riga East Clinical University Hospital Latvian Oncology Centre, Riga
Christchurch Clinical Studies Trust Ltd, Christchurch
Centro Medico Monte Carmelo, Arequipa
Clinica Internacional, Sede San Borja, Lima
Regionalny Szpital Specjalistyczny im. W. Bieganskiego, Grudzi?dz
Centrum Terapii Wspolczesnej, Lodz
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Warsaw
Wilgers Oncology Centre, Pretoria
Asan Medical Center, Seoul
Samsung Medical Centre, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hacettepe Uni Medical Faculty Hospital, Ankara
Ankara Bilkent City Hospital, Ankara
Birmingham Heartlands Hospital, Birmingham
Hoffmann-La Roche
INDUSTRY